96 /100
CRITICAL RISK
Score updated May 21, 2026

LOCL — Local Bounti Corporation Dilution Risk Tracker

Track LOCL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LOCL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
100
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
55%
📜 Warrant Exercise 60%
• Massive warrant overhang: 356% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise 55%
• Critical: only 0.9 months cash remaining
🔄 Reverse Split 45%
• 50-day avg $1.62 approaching $1 threshold
• Only 1 months cash — financial pressure
🔔 Track LOCL — Get forecast alerts →

💹 Market Data

Market Cap$42.57M
Shares Outstanding22.80M
Float640.9K
Cash$4.23M
Debt$535.52M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 1.25M shares
#1 Cresset Asset Management, LLC 213.0K shares
#2 BBR Partners, LLC 194.7K shares
#3 FMR, LLC 119.0K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest181.5K
Days to Cover1.0
% of Float28.3%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
Form 4 INSIDER TRANSACTION May 01, 2026
Form 4 INSIDER TRANSACTION May 01, 2026
Form 4 INSIDER TRANSACTION May 01, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track LOCL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LOCL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for LOCL
📊 LOCL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LOCL Signal Convergence & Dark Pool Activity — StonkWhisper 📄 LOCL Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.